flare-5

P4A’s extensive global database of Orphan
Drugs, Cell and Gene Therapy analogues

Greetings Traveller,

Welcome to the Portal.

My name is XINTA, curator
and controller of P4A’s rare
disease analogue database.

Combined with P4A’s expertise in the space we team up to provide
a premium bespoke service that delivers both quality with agility

Assess quality 
of evidence for
your product

Gauge the 
robustness of 
pricing stategies

Find the optimal 
access pathway 
for your product

Learn HTA pricing 
outcomes from 
competitors

xinta-no-tagline

How does the process work?

1

Contact XINTA with your key questions

2

XINTA shares quote and gets sign-off on scope and budget

3

P4A will then connect to understand your situation & scope options

4

Project kick-off call to align on selection criteria and analogues to take forward for analysis

5

XINTA documents, analyses and interprets key learnings from analogues

6

Alignment call to share learnings and get buy-in to recommendations

7

P4A experts develop recommendations tailored to your specific situation

Want to find out more information about XINTA?

Get in touch with us